• UCLA Health
  • myUCLAhealth
  • School of Medicine
UCLA Urology

UCLA Urology

UCLA Urology
  • About Us
    • Chair's Welcome
    • Awards and Recognition
    • Innovations and Technology
    • UCLA Institute of Urologic Oncology
    • Webinars
    • Contact Us
    • News and Events
    • Newsletters
    • Media Contact
    • Our History
    • Our Milestones
    • The Men's Clinic at UCLA
    • Jobs
    • Giving
  • Clinical Programs
    • Bladder Cancer
    • General Adult Urology
    • Kidney Cancer
    • Kidney Stone Center
    • Kidney Transplant Program
    • Male Urology
    • Minimally Invasive/Robotics Surgery
    • Pediatric Urology Program
    • Pelvic Medicine and Reconstruction
    • Prostate Cancer Program
    • Testicular Cancer
    • Urologic Oncology
  • Conditions Treated
    • Alphabetical List of Conditions
    • Adult Conditions
    • Cancer Conditions
    • Female Conditions
    • Male Conditions
    • Pediatric Conditions
  • For Patients
    • Appointment Request
    • myUCLAhealth
    • Clinical Updates
    • Community Impact
    • Contact Us
    • Preparing for Surgery
    • Healthy at Every Age
    • Interactive Procedure Videos
    • Maps and Directions
    • Patient Education
    • Patient Stories
    • Video Gallery
    • Webinars
    • Vital Signs Publications
    • UCLA Blood Donation
    • UCLA Overnight Accommodations
    • Urology Portal
  • Research
    • Bladder Cancer Research
    • Kidney Cancer Research
    • Male Urology Research
    • Pediatric Urology Research
    • Prostate Cancer Research
    • SPORE In Prostate Cancer
    • Health Services Research
    • Clinical Trials
  • Education
    • Fellowship Program
    • Medical Students
    • Residency Program
    • Resources and Publications
  • For Healthcare Professionals
    • How to Refer a Patient
    • Educational Opportunities
    • Physicians Updates & Clinical Updates
    • Publications by Urology Faculty
    • Events and CME Courses
    • eReferrals
  • Physician Directory
    • All Faculty (A-Z)
    • UCLA Faculty and Providers
    • UCLA Faculty - Affiliated Institutions
    • Joint Appointments/Research Faculty
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Urology

Kidney Cancer Diagnosis: Learn More...

  1. Home
  2. Kidney Cancer Diagnosis: Learn More...

Kidney Cancer Diagnosis: Learn More...

Share this

Kidney Cancer Diagnosis Continued...

Stages of Kidney Cancer Continued...

Although grading and the identification of cancer cell types help determine a patient's prognosis, most doctors believe that the most important factor in predicting prognosis, as well as the treatment options, is the "stage" of the cancer. Staging is the process of gathering information from physical examinations and diagnostic tests to determine the size and location of the tumor and how widespread a cancer is. Diagnostic tests include imaging studies such as CT scans and MRIs.

Staging Factors that Influence a Patient's Prognosis Continued...

  • Spread to tissues surrounding the kidney
  • Spread to contiguous organs (organs next to the kidney)
  • Spread to nearby lymph nodes (the small, bean-shaped structures found throughout the body that produce and store infection-fighting cells)
  • Spread to other organs like lung, bone, liver (distant metastasis)

The treatment and prognosis for renal cell carcinoma will depend significantly on its stage. There are two common staging systems for RCC, the TNM System (include TNM info below as a pop-up window) and the University of California Los Angeles Integrated Staging System (UISS) System. (include UISS info below as a pop-up window) The Fuhrman Grading System is a system used to describe how kidney tumors appear under the microscope. (include Furhman info below as a pop-up window)

TNM Staging System The most commonly used staging system is that of the American Joint Committee on Cancer (AJCC), also known as the TNM Staging System. The TNM (tumor-node-metastasis) system uses stages generally similar to those of the Robson system and is becoming more widely accepted because it provides a more detailed description of the tumor(s).

  • The letter T followed by a number from 0 to 4 describes the tumor's size and spread to nearby tissues. Some of these numbers are further subdivided with letters, such as T1a and T1b. Higher T numbers indicate a larger tumor and/or more extensive spread to tissues near the kidney.
  • The letter N followed by a number from 0 to 2 indicates whether the cancer has spread to lymph nodes near the kidney and, if so, how many are affected. Lymph nodes are bean-sized collections of immune system cells that help the body to fight infections and cancers.
  • The letter M followed by a 0 or 1 indicates whether or not the cancer has spread (metastasized) to other organs such as the lungs or bones, or to lymph nodes that are not near to the kidneys.

"T" STAGE

Primary Tumor Stage (T Stage)

Graphic Representation

Description

T1

< 4 cm: T 1a
4 - < 7 cm: T 1b

 T1

Tumor is confined to the kidney (no penetration through the capsule) and is no greater than 7 cm in dimension.

T2

 T2

Tumor is confined to the kidney (no penetration through the capsule) and is greater than 7 cm in dimension

T3a

 T3a

Tumor penetrates through the kidney capsule into the surrounding fat or the adrenal gland, but not through Gerota's fascia.

T3b or T3c

T3b
T3c

Tumor extends into the renal vein or into the vena cava.  (T3b indicates that the tumor thrombus does not extend above the level of the diaphragm. T3c indicates that the tumor thrombus extends above the level of the diaphragm.)

T4

T4

Tumor penetrates through Gerota's fascia.

"N" STAGE

Regional Lymph Nodes
(N stage)

Description

N0

No cancer in the lymph nodes

N1

Cancer in a single lymph node

N2

Cancer in more than one lymph node

"M" STAGE

Distant Metastasis
(M Stage)

Description

M0

No metastasis

M1

Distant metastasis present

 

The UCLA Integrated Staging System (UISS) Continued...

The UCLA Integrated Staging System (UISS), developed by translational researchers within the UCLA Department of Urology, is a more complex but probably more accurate system that incorporates the TNM staging systems, a person's overall health and the Fuhrman grade of the tumor.

In the UISS system: Patients without any tumor spread are divided into three groups: low risk, intermediate risk and high risk.

  • The Low Risk group is considered Stage I; are in excellent health other than the cancer and have a low Fuhrman grade tumor.
  • The Intermediate Risk group is all others, without any spread.
  • The High Risk group is either Stage III (but without lymph node spread), in poor health and have a high Fuhrman grade score; or Stage IV (without any spread, T4, N0, M0).

The most recent five-year cancer-specific survival data for the low risk group is 91%, for the intermediate risk group is 80%, and for the high risk group is 55%.

Patients with tumor spread, to lymph nodes or distance sites such as bone, lung or liver, are also divided into these three groups. Low risk patients have a tumor that is T1-3, N1, M0. High risk patients have a T4 tumor, poor health and high Fuhrman grade or distant spread. Intermediate grades are all others. The five-year cancer-specific survival is lower in these people whose tumors have spread: for the low risk group it is 32%, for the intermediate risk group 20% and for the high risk group 0%.

Fuhrman Grading Scale for Kidney Cancer Continued...

Another important factor used by doctors in assessing renal cell carcinoma is its Fuhrman grade (named after the pathologist who developed the system). This refers to how closely the cancer cells look like normal kidney cells under a microscope.

The Fuhrman grading system ranks tumor cells on a scale of 1 through 4.

Grade 1 tumor cells don't look very different from normal kidney cells. Grade 1 cancers typically grow and spread slowly and most often have a good prognosis. On the other hand, Grade 4 tumor cells look quite different from normal kidney cells and have a worse prognosis.

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest Follow us on Flickr Follow us on Sharecare
  • UCLA Health
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Publications
  • Giving
  • Careers
  • Volunteer
  • Privacy Practices
  • Nondiscrimination
  • Emergency
  • Smoke-Free
  • Terms of Use
  • 1-800-UCLA-MD1
  • Maps & Directions
  • Contact Us
  • Report Broken Links
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest Follow us on Flickr Follow us on Sharecare